Not known Factual Statements About conolidine
Andy Chevigné and his group, RTI-5152-twelve is postulated to enhance the amounts of opioid peptides that bind to classical opioid receptors in the brain, leading to heightened painkilling activity. The LIH-RTI investigation groups proven a collaboration agreement and filed a joint patent application in December 2020.In 2011, the Bohn lab pointed